<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04841317</url>
  </required_header>
  <id_info>
    <org_study_id>59671</org_study_id>
    <secondary_id>20FRN35360178</secondary_id>
    <nct_id>NCT04841317</nct_id>
  </id_info>
  <brief_title>Mobile Technology for Blood Pressure Management</brief_title>
  <official_title>Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to assess the feasibility and effectiveness of a&#xD;
      mobile-technology based system that integrates patient-facing and clinician-facing components&#xD;
      to assist the management of hypertension.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 31, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Systolic and diastolic blood pressures for each participant measured by home blood pressure monitoring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant survey</measure>
    <time_frame>12 weeks</time_frame>
    <description>A survey regarding usability and feedback about the intervention completed by participants</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Single-arm: Blood pressure intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will use a mobile technology system comprising of a remote home blood pressure monitoring cuff and a mobile application integrated with a clinician-facing component to view and manage remote blood pressures. Participants will use this for 12 weeks, with assessment of blood pressure outcomes and anonymous surveys regarding the technology at 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Mobile technology intervention</intervention_name>
    <description>Home blood pressure cuff used by patients twice a week, with blood pressures transmitted to providers remotely</description>
    <arm_group_label>Single-arm: Blood pressure intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older with an established diagnosis of essential hypertension&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients on more than 2 antihypertensives at time of enrollment&#xD;
&#xD;
          -  Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary&#xD;
             cause, including but not limited to the following:&#xD;
&#xD;
          -  Renal artery stenosis&#xD;
&#xD;
          -  Primary hyperaldosteronism&#xD;
&#xD;
          -  Cushing syndrome&#xD;
&#xD;
          -  Coarctation of the aorta&#xD;
&#xD;
          -  Drug-induced hypertension&#xD;
&#xD;
          -  Pheochromocytoma&#xD;
&#xD;
          -  Obstructive sleep apnea&#xD;
&#xD;
          -  Hospitalization for malignant hypertension or severe hypertension (including stroke,&#xD;
             cardiac events, acute kidney injury) in the preceding 6 months&#xD;
&#xD;
          -  Hospitalization for unstable angina or myocardial infarction in the preceding 6 months&#xD;
&#xD;
          -  Prior diagnosis of heart failure or cardiomyopathy&#xD;
&#xD;
          -  Stroke or transient ischemic attack within prior 6 months&#xD;
&#xD;
          -  Prior organ transplantation&#xD;
&#xD;
          -  Failure to obtain informed consent&#xD;
&#xD;
          -  Pregnant or currently trying to become pregnant&#xD;
&#xD;
          -  Patients who are enrolled in other research studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paul Wang</last_name>
    <phone>(650) 723-9363</phone>
    <email>paul.j.wang@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Wang</last_name>
      <phone>650-723-9363</phone>
      <email>paul.j.wang@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13. Review. Erratum in: Hypertension. 2018 Jun;71(6):e140-e144.</citation>
    <PMID>29133356</PMID>
  </reference>
  <reference>
    <citation>Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13. Erratum in: Lancet. 2003 Mar 22;361(9362):1060.</citation>
    <PMID>12493255</PMID>
  </reference>
  <reference>
    <citation>Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009 May 19;338:b1665. doi: 10.1136/bmj.b1665. Review.</citation>
    <PMID>19454737</PMID>
  </reference>
  <reference>
    <citation>Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013 Aug 21;310(7):699-705. doi: 10.1001/jama.2013.108769.</citation>
    <PMID>23989679</PMID>
  </reference>
  <reference>
    <citation>Logan AG, Irvine MJ, McIsaac WJ, Tisler A, Rossos PG, Easty A, Feig DS, Cafazzo JA. Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics. Hypertension. 2012 Jul;60(1):51-7. doi: 10.1161/HYPERTENSIONAHA.111.188409. Epub 2012 May 21.</citation>
    <PMID>22615116</PMID>
  </reference>
  <reference>
    <citation>Logan AG, McIsaac WJ, Tisler A, Irvine MJ, Saunders A, Dunai A, Rizo CA, Feig DS, Hamill M, Trudel M, Cafazzo JA. Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens. 2007 Sep;20(9):942-8.</citation>
    <PMID>17765133</PMID>
  </reference>
  <reference>
    <citation>Casey DE Jr, Thomas RJ, Bhalla V, Commodore-Mensah Y, Heidenreich PA, Kolte D, Muntner P, Smith SC Jr, Spertus JA, Windle JR, Wozniak GD, Ziaeian B. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2019 Nov 26;74(21):2661-2706. doi: 10.1016/j.jacc.2019.10.001.</citation>
    <PMID>31732293</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>April 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Paul Wang</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

